Trials Sponsors Conditions Drugs Pricing

Conditions

Avascular Necrosis of Hip Degenerative Hip Joint Disease

Outcome Measures

Primary Outcomes (1)

Change of FIBTEM
FIBTEM: one of the measurements of the rotational thromboelastometry
5 minutes before initiation of anesthesia and 5 minutes after finishing operation

Secondary Outcomes (16)

volume of infused fluid during operation
Period from starting to finishing the operation (During operation, an expected average of 3 hours)
intraoperative urine output
Period from starting to finishing the operation (During operation, an expected average of 3 hours)
transfusion units
Period from starting to finishing the operation (During operation, an expected average of 3 hours) and postoperative first day
postoperative bleeding volume
postoperative 72 hours
Hemoglobin
preoperative day 1
+11 more secondary outcomes

Study Arms (1)

RTHRA group

patients undergoing revision total hip replacement

Other: RTHRA group

Interventions

RTHRA groupOther

hematologic variables measurement in patients undergoing revision total hip replacement

RTHRA group

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age20 Years - 85 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Patients undergoing revision total hip replacement

You may qualify if:

revision total hip replacement

You may not qualify if:

Sponsors & Collaborators

Seoul National University Bundang Hospital
Otherlead

Study Sites (1)

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, 13620, South Korea

MeSH Terms

Conditions

Osteoarthritis, Hip

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

Hyo-Seok Na, MD, PhD
Seoul National University Bundang Hospital
PRINCIPAL INVESTIGATOR

Enrollment

62 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: CASE ONLY
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Associate Professor

Study Record Dates

First Submitted

October 24, 2016

First Posted

November 1, 2016

Study Start

April 2015

Actual (reported)

Revision Total Hip Replacement Arthroplasty and Hematologic Variables

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (16)

Study Arms (1)

RTHRA group

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (16)

Study Arms (1)

RTHRA group

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Data Sharing

Source record

Locations